PROMOTING ACCESS TO AFRICAN RESEARCH

Tropical Journal of Pharmaceutical Research

Log in or Register to get access to full text downloads.

Remember me or Register



Screening and Mechanism of Trapping Ligand Antagonist Peptide for Chemokine Receptor US28 of Human Cytomegalovirus

H Liu, H Sun, L Li, X Mo, X Li, G Zhang

Abstract


Purpose: The aim of the present study was to develop peptide H9 as an efficient antagonist of human cytomegalovirus (HCMV) chemokine receptor US28.
Methods: US28 gene was amplified from HCMV, and a stable expression system was constructed using NIH/3T3 cells. Interaction between peptide H9 and receptor US28 was tested by enzyme-linked immunosorbent assay. Flow cytometry was used to determine intracellular concentrations of Ca2+, and the possible role of H9 as an antagonist was evaluated by anti-viral experiments.
Results: H9 interacts with the US28 receptor and prevents an increase of Ca2+ resulting from an interaction of chemokine with its receptor. Anti-viral assays showed that H9 could inhibit cytopathic effects of HCMV. AD169 infection (EC50 = 0.46 ng/ml), and the production of pp65 antigen were strongly inhibited with an EC50 value of 0.34 ng/ml.
Conclusion: The results demonstrate that H9 is an antagonist of US28, suggesting a possible role as a treatment for HCMV.

Keywords: Human cytomegalovirus, US28, Peptide H9, Trapping receptor/ligand, Antagonist




http://dx.doi.org/10.4314/tjpr.v11i2.4
AJOL African Journals Online